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Introduction
Hemiparesis is common following stroke. Reduced upper
limb function impacts on ability to perform activities of daily
living (Page et al 2004), which is likely to reduce
independence and increase burden of care. Constraint-
induced movement therapy (CIMT) is a family of techniques
that have been implemented to increase the amount and
quality of function of an affected upper limb. These
techniques involve restraint of the intact limb over an
extended period, in combination with a large number of
repetitions of task-specific training of the affected limb.
CIMT evolved when it was observed that monkeys stopped
using an affected upper extremity immediately after unilateral
deafferentation by dorsal rhizotomy and never spontaneously
resumed use (Knapp et al 1958, Knapp et al 1963, Taub
1977). It was proposed that animals could learn ‘non-use’
when attempts to use an affected limb immediately following
injury are unsuccessful. Subsequent research identified that
use of a deafferented arm could be induced by either
immobilising the unaffected arm for a period of days or by
training the affected arm (Taub 1980). When movement was
restricted for a period of one to two days, the animal would
use the limb while the restriction was in place but revert to
non-use as soon as it was removed. However, when the
restriction was imposed for a period of one to two weeks, use
of the affected upper extremity was maintained after the
restriction was removed. This mechanism of learned non-use
is thought to apply in humans who suffer hemiparesis
following stroke, where the initial period of motor
incapacitation is due to cortical injury (Taub et al 1999).
The first investigation into the effects of CIMT on humans,
involving both training of the paretic upper limb (six hours a
day each weekday for two weeks) and restraint of the
contralateral upper limb (90% of waking hours for 14
consecutive days) was described by Taub (1980). CIMT has
continued to evolve and now constitutes a family of
treatments encompassing motor restriction of the unaffected
upper extremity and training of the affected extremity. For the
purpose of this review, trials utilising Taub’s original protocol
have been defined as CIMT. Protocols in which the duration
of treatment, the amount of therapy, or the constraint regimen
differs from that described by Taub are referred to as
‘modified’ CIMT (mCIMT).
Attention was drawn to the potential harms of CIMT when
lesion enlargement was described in rats given intense motor
activity shortly following cortical lesion (Risedal et al 1999).
Review aims therefore included examination of evidence of
harms as well as of benefits.
The primary aim of this review was to assess the effectiveness
of CIMT for improving upper limb function following stroke.
Secondary aims were to assess effects of CIMT on quality of
life and ability to perform activities of daily living. In
addition, we wished to describe protocols that have been
defined as CIMT and, if possible, compare the
compliance/effectiveness of different protocols, describe the
inclusion criteria that have been used to admit patients into
trials of CIMT and document potential harms associated with
CIMT such as incidence of falls or other injuries that might
be a consequence of the treatment protocol. For practical
application of review findings, we also considered it
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important to consider intervention effects in the context of
costs associated with delivering CIMT.
Method
To identify all randomised controlled trials and systematic
reviews of relevant randomised controlled trials, a
computerised search of the following bibliographic databases
was conducted: Medline (OVID) 1966 to Week 11, 2005;
CINAHL (OVID) 1982 to Week 11, 2005; EMBASE (OVID)
1988 to Week 11, 2005; The Cochrane Library (Database of
Systematic Reviews, Database of Reviews of Effects, Central
Register of Controlled Trials) Issue 1, 2005; PEDro, to March
2005; and OTseeker, to March 2005.
A comprehensive search strategy was built on the search
strategy of the Stroke group of the Cochrane Collaboration
(Sandercock et al 2003) and utilised specific terms for
identifying work in the field of CIMT. (The full search
strategy is available as an eAddendum at the Australian
Journal of Physiotherapy website.) In addition, the reference
lists of all included trials were hand searched.
The two authors independently identified trials meeting the
inclusion criteria, utilising title and abstract. In instances of
uncertainty the full article was obtained. Disagreements
between reviewers were settled through discussion. Table 1
lists the criteria for inclusion of trials.
The method quality of included trials was assessed
independently by the two authors using the PEDro scale
(Maher et al 2003, Moseley et al 2002). Disagreements were
resolved through discussion. The PEDro scale contains ten
criteria, each scoring either 1 for yes or 0 for no (Maher et al
2003). The scale assesses randomisation, allocation
concealment, comparability at baseline, blinding of subjects,
blinding of therapists, blinding of assessors, measurement of
at least one key outcome obtained from more than 85% of the
subjects initially allocated to groups, intention to treat
analysis, between-group comparison tested statistically for at
least one key outcome measure, and point measures and
measures of variability provided for at least one key outcome
measure. As blinding of subjects and therapists is impractical
in trials of CIMT the maximum possible score was 8/10.
Data were extracted independently by the two authors for all
included trials using a standardised form. Disagreements
were resolved through discussion. Extracted data are
available as an eAddendum at the Australian Journal of
Physiotherapy website.
As all outcomes were assessed using scales considered to be
continuous, the number of participants, pre- and post-
intervention means, and standard deviations of measurements
were extracted for all groups. In all trials where the required
data were not reported, data were sought from the authors.
Where possible, the effect size (Hedges g) for the intervention
was calculated. For the purpose of this review an effect size
of 0.2 to 0.49 was considered to be small, 0.5 to 0.79
moderate, and above 0.8 large (Cohen 1988).
Where appropriate, statistical pooling was performed using
the method outlined by Fleiss (1993). A fixed effects model
was used in cases where there was no significant between-
trial variation. A random effects model was used where
statistical heterogeneity was apparent. In instances where
more than one comparison was available for a single outcome
measure from the same trial, the more conservative estimate
of effect was entered into meta-analysis.
Results
The search yielded 1339 citations. Following exclusion based
on title and abstract, 40 full articles were obtained. Four
systematic reviews and 14 randomised controlled trials met
inclusion criteria.
Two included reviews (van der Lee 2001, van der Lee 2003)
specifically evaluated CIMT. Both were based on a previous
systematic review (van der Lee et al 2001) of exercise therapy
for arm function. The most recent of these reviews included
only four (Dromerick et al 2000, Page et al 2002, Taub et al
1993, van der Lee et al 1999) of the 14 trials identified in this
review. Neither of these reviews described study selection,
data extraction methods, or validity assessment. A third
included review (Barreca et al 2003) of treatment
interventions for the paretic upper limb identified two trials of
CIMT. Conclusions regarding effects of CIMT were
constrained by the limited available evidence and no validity
assessment of included trials was reported. A more recent
systematic review (Van Peppen et al 2004) that assessed the
impact of physical therapy on functional outcomes after
stroke identified six relevant trials of CIMT. Significant
results were reported in favour of CIMT for one of two
pooled outcome measures.
One protocol for a systematic review of the effectiveness of
traditional CIMT on stroke patients was identified (Sitori et al
2003). Results were not available.
Fourteen randomised controlled trials (Alberts et al 2004,
Atteya 2004, Dromerick et al 2000, Page et al 2005, Page et
al 2002, Page et al 2004, Page et al 2001, Ploughman and
Corbett 2004; Ro et al in press, Sterr et al 2002, Suputtitada
et al 2004, Taub et al 1993, van der Lee et al 1999, Wittenberg
et al 2003) met the inclusion criteria. The trial by Ro et al (in
press) was obtained from the authors to supplement the
previously reported summary of results (Grotta et al 2004;
Noser et al 2003).
Of the 14 trials, nine were conducted in the United States with
a total of 113 participants (Alberts et al 2004, Dromerick et al
2000, Page et al 2005, Page et al 2002, Page et al 2004, Page
et al 2001, Ro et al in press, Taub et al 1993, Wittenberg et al
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Table 1.  Criteria for inclusion of trials in this study.
• Some form of CIMT was compared with no intervention
or with alternative treatment. Papers reporting CIMT
provided in concert with other interventions were
eligible for inclusion provided these other interventions
were applied equally to comparison group(s).
• Trial participants were over 18 years and exhibited
reduced functional use of an upper extremity as a result
of a stroke.
• The study design was either a randomised or quasi-
randomised controlled trial including cross-over designs
or a systematic review of randomised controlled trials.
• The trial reported scores for at least one measure of
upper limb function.
• Trials were reported in English. Funding was not
available for translation.
• Results were reported in journal publications.
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2003) one in the United Kingdom (15 participants) (Sterr et al
2002), one in Thailand with 69 participants (Suputtitada et al
2004), one in Saudi Arabia with six participants (Atteya
2004), one in Canada with 23 participants (Ploughman and
Corbett 2004), and one in the Netherlands with 66
participants (van der Lee et al 1999).
Participants across all trials had similar diagnoses of upper
limb hemiparesis following stroke. Sterr et al (2002) included
two participants with traumatic brain injury in a sample of 15.
Table 2 details trial inclusion criteria for participants. All
trials except two (Dromerick et al 2000, Ploughman and
Corbett 2004) required subjects to have a minimum of 10
degrees of active finger extension and 20 degrees of active
wrist extension. A minimum level of cognitive function was
specified in all except two trials (Ro et al in press, Wittenberg
et al 2003). Half of the trials excluded patients if they
displayed evidence of excessive spasticity (Atteya 2004, Page
et al 2005, Page et al 2002, Page et al 2004, Page et al 2001,
Sterr et al 2002, Taub et al 1993) and two trials (Dromerick et
al 2000, Suputtitada et al 2004) required participants to have
intact sensation and protective reactions.
The duration of the trial, setting, type and time of restraint,
and intensity and type of therapy varied across trials (Tables
3 and 4). Four trials followed patients beyond the post-
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Table 2. Criteria for inclusion of participants in studies.
Criteria Study (first author)
Alberts Atteya Drom- Page Page Page Page Plough- Ro Sterr Suputti- Taub van der Witten- 
erick man tada Lee berg
2004 2004 2000 2001 2002 2004 2005 2004 in press 2002 2004 1993 1999 2003
Time since onset 3–9 1–6 < 14 1–6 1–6 > 12 < 14 < 4 < 14 >12 12–120 > 12 > 12 > 12
of stroke mths mths days mths mths mths days mths days mths mths mths mths mths
Age (years) >18 18–75 – 18–95 18–95 18–95 18–95 < 75 – – 18–80 < 75 18–80 –
Specified diagnosis X X – X X X X X – – X – X X
Specified side – – – – – – – – – – – X X –
of hemiplegia
Able to extend X X – X X X X – X X X X X X
at least 10° at the fingers
Able to extend X X – X X X X – – X X X X X
at least 20° at the wrist
No evidence of – X – X X X X – – X – X – –
excessive spasticity
No evidence of X X – X X X X – – – – – – –
excessive pain
Measurement of X – X – – – X X X – X X X X
reduced upper limb 
function
Intact sensation / – – X – – – – – – – X – – –
protective reactions
Specified level of X X X X X X X X – X X X X –
cognitive function
Specified level of – – – – – – – – X X X – X –
communication
Specified level of X – – – – – – – X X X X –
standing balance
Not participating in X X – X X X – – – X – – – –
an active rehabilitation 
program
Not part of other – X – X X X X – – – – – – –
experimental studies
No upper limb – – X – – – – – – – – – – –
conditions limiting 
use before stroke
No other significant X – – – – – – – – – – X – –
medical conditions
Minimum passive X – – – – – – – – – – – – –
range of movement of 
the affected upper limb
Specification of X – – – – – – – – – – X – –
hand dominance
X = inclusion criteria
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intervention assessment, reporting outcomes at one month
(Sterr et al 2002), three months (Ro et al in press), 12 months
(van der Lee et al 1999) and 24 months (Taub et al 1993).
The method quality of included trials is detailed in Table 5.
The average PEDro score of included trials was 5/10 (range 3
to 7). Although randomisation procedures appeared adequate
for the trial reported by van der Lee et al (1999) 21 of 66
subjects did not stay in the group to which they were
allocated. Participant eligibility criteria and treatment and
control interventions were well defined in all trials.
Table 6 describes the interventions that were compared and
the post-intervention between-group effect sizes for the
outcome measures used in more than one trial. Meta-analyses
were performed for five outcome measures and revealed
moderate to large effect sizes across all calculations, only one
of which attained statistical significance (Table 6). The results
from the trial by van der Lee et al (1999) were excluded in the
pooling due to the aberrations from the randomisation
schedule and significant differences between the groups at
baseline.
Traditional CIMT versus alternative therapy or control
Four of the thirteen trials compared traditional CIMT, or a
minor variation of CIMT, to alternative therapy (Suputtitada
et al 2004, Taub et al 1993, van der Lee et al 1999, Wittenberg
et al 2003) and one trial compared traditional CIMT to a no
treatment control (Alberts et al 2004).
All four trials comparing CIMT to alternative therapy
included participants who had suffered stroke more than a
year before the trial. One trial (van der Lee et al 1999)
(PEDro score 6) with a sample size of 66, found significant
differences between the groups on three of six outcome
measures at the end of the treatment period, with moderate
effect sizes (Table 6). These differences were maintained over
the 12 month follow-up period. However, the authors
reported that all significant between-group differences were
lost when an intention-to-treat analysis was performed.
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Table 3. Description of restraint procedures.
Study (first author) Type of restraint Amount of restraint Measure of 
restraint compliance
Alberts 2004 Hand placed in a mitt Goal of 90% of waking hours Nil
Atteya 2004 Hand in a mesh polystyrene-filled Every weekday for the 5 hours identified Log book
mitt with Velcro straps around the as a time of frequent arm use
wrist and arm in a cotton hemi-sling
Dromerick 2000 Padded mitten At least 6 hours per day Nil
Page 2001 Hand in a mesh polystyrene-filled Every weekday for the 5 hours identified Weekly telephone
mitt and arm in a cotton sling as a time of frequent arm use calls and a log book
Page 2002 Hand in a mesh polystyrene-filled Every weekday for the 5 hours identified Informal in-clinic 
mitt and arm in a cotton hemi-sling as a time of frequent arm use interviews and a log
book
Page 2004 Hand in a mesh polystyrene-filled Every weekday for the 5 hours identified Log book
mitt with Velcro straps around the as a time of frequent arm use
wrist and arm in a cotton hemi-sling
Page 2005 Polystyrene-filled mitt with Every weekday for the 5 hours identified Log book
Velcro straps around the wrist as a time of frequent arm use
Ploughman 2004 Long, thick knitted acrylic, thumbless Increased progressively, beginning with Weekly meeting with
mitten 1 hour per day and increased to 6 hours principal investigator
per day from week 2 onwards to assess hours of
mitten wearing
Ro in press Mitten Target of 90% of waking hours, except Not described
during activities where safety would be 
compromised by wearing the restraint
Sterr 2002 If the patient had no balance Target of 90% of waking hours every Nil
problems – resting hand splint and day of the week
arm sling
With balance problems – specially 
designed half-glove
Suputtitada 2004 Glove During therapy time Nil
Taub 1993 Resting hand splint and sling Worn at all times during waking hours, Nil
secured at both ends every day of the week, except for 
specific activities (e.g. toileting, where 
balance compromised); > 90% of 
waking hours
van der Lee 1999 Resting hand splint and closed arm Patients instructed not to wear splint Log book
sling, attached to the waist (sling for travelling, sleeping, dressing or 
attached during treatment only) during toilet activities
Wittenberg 2003 Hand splint and sling During waking hours Nil
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Table 4. Summary of trial design features.
Study Duration Setting Intensity of Type of therapy Additional
(first author) of trial therapy therapy
Alberts 2 weeks Outpatient CIMT: 6 hours/ One on one therapy with a rehabilitation Nil Reported
2004 day, 5 days/week specialist using shaping or adaptive task practice  
Control: Nil and repetitive task practice
Atteya 10 weeks Outpatient 1/2 hour PT and Both: 80% of PT and OT sessions focused on Nil reported
2004 1/2 hour OT, 3 neuromuscular facilitation techniques with
times/week emphasis on ADL tasks and 20% focused on 
compensatory techniques using unaffected side. 
CIMT: Identification of 2 functional tasks on the 
WMFT that were practised for at least 5 minutes 
as part of the UL program, ‘shaping’ techniques
utilised
Dromerick 2 weeks Inpatient 2 hours/day, CIMT: Treatment directing effort and attention to Routine
2000 5 days/week hemiparetic UL and minimising use of uninvolved interdisciplinary
UL during functional activities; circuit training stroke 
encouraging use of hemiplegic arm with a variety treatment –
of UL and functional tasks individualised
Alternative: Standard OT treatment including and circuit
compensatory techniques for ADL, UL strength training
and ROM and traditional positioning; circuit techniques
training program allowing bilateral self-ROM and 
functional activities in a supervised setting
Page 10 weeks Outpatient 1/2 hour PT and Both: 80% of PT and OT sessions focused on Nil reported
2001 1/2 hour OT, 3 neuromuscular facilitation techniques with 
times/week emphasis on ADL tasks and 20% focused on
compensatory techniques using unaffected side. 
CIMT: Identification of 2 functional tasks on the 
WMFT that were practised for at least 5 minutes 
as part of the UL program, ‘shaping’ techniques 
utilised
Page 2002 10 weeks Outpatient 1/2 hour PT and CIMT: OT concentrating on affected UL use in Nil reported
1/2 hour OT, valued functional tasks, 5 min of shaping techniques
3 times/week to improve 2–3 valued functional tasks; PT more 
affected UL stretching, dynamic stand/balance 
activities and gait training
Alternative: Treated according to neuromuscular 
facilitation techniques for the majority of the time; 
some compensatory techniques also taught
Page 10 weeks Outpatient 1/2 hour PT and CIMT: OT 20–25 minutes concentrating on Nil reported
2004 1/2 hour OT, affected UL use in functional task and
3 times/week approximately 5 minutes of strengthening and/or
compensatory techniques using the less affected 
UL as required; PT largely focused on lower limb 
activities with some time spent on UL stretching to 
facilitate ADLs
Alternative: 80% of PT and OT sessions focused 
on neuromuscular facilitation techniques with 
emphasis on functional tasks as well as stretching 
of the affected UL and 20% focused on 
compensatory techniques using unaffected side.
Control: No treatment
Page 10 weeks Outpatient 1/2 hour therapy CIMT: Approximately 25 minutes, using shaping Nil reported
2005 session 3 times techniques, to concentrate on affected UL use in
a week three ADL tasks chosen by the patients and the 
treating therapist; as required, approximately five 
minutes focusing on more affected UL range of 
movement 
Alternative: Standard therapy for the affected UL
including weight-bearing activities, manual dexterity 
exercises (e.g. grasp release, stacking cones) and 
teaching of ADLs using the less affected side
Ploughman For the Inpatient/ As clinically Both groups received proximal motor control Not Applicable
2004 rehabilitation Outpatient indicated progressing to skilled task training progressing to 
period strength and endurance training
Ro 2 weeks Inpatient/ 3 hours/day, CIMT: Shaping technique, repeatedly presenting Nil Reported
in press Outpatient 6 days a week the performance goal to the patient, continuous 
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verbal feedback and presenting a trial-by-trial 
graphic representation of performance trends
Alternative: Focus was to increase independence 
with ADLs using compensatory techniques as 
needed using active and/or active assisted ROM, 
bimanual and unilateral activities, tone modification 
and ADLs using modified or compensatory methods; 
depending on severity of motor weakness 
strengthening and co-ordination exercises of the 
affected side were also used
Sterr 2 weeks Outpatient CIMT: 6 hours/ Training using a ‘shaping’ technique Nil reported
2002 day, every weekday
Alternative: 3 hrs/
day every weekday 
Suputtitada 2 weeks Outpatient 6 hours/day every CIMT: Affected UL training Nil reported
2004 weekday Alternative: Treatment according to NDT; all 
activities performed bimanually and, if necessary, 
the affected arm was supported with the unaffected 
hand; symmetry of posture and inhibition of in-
appropriate ‘synergistic’ movements emphasised
Taub 1993 2 weeks Outpatient CIMT: 6 hours/ CIMT: Therapy consisted of a variety of tasks for Nil reported
day, every weekday the paretic UL (e.g. eating lunch with a fork and 
Alternative: 2 PT spoon, throwing a ball, playing dominoes, card 
sessions games, writing on paper, writing on a chalk board, 
pushing a broom, Purdue Dexterity Board, 
Minnesota Rate of Manipulation Test)
Alternative: Patients told during four 10-minute 
periods on separate days that they had much 
greater motor ability with their affected upper 
extremity than they were exhibiting – encouraged 
to use the affected UL as much as possible at home; 
in the two PT sessions the therapist determined 
passive ROM, joint play, muscle tone and sensory 
loss; patients given self ROM exercises to carry out 
at home for 15 min per day, where the affected UL
was passively moved into a variety of positions by 
unaffected UL
van der Lee 12 days Outpatient 6 hours/day, 5 Treatment according to NDT; all activities Group
1999 days per week performed bimanually and, if necessary, the  activities,
affected arm was supported with the unaffected exercises and
hand; symmetry of posture and inhibition of therapist
inappropriate ‘synergistic’ movements emphasised; attention
practice based on functional goals and treatment 
focused on housekeeping activities, handicrafts and
games; groups supervised by one or two physical
or occupational therapists and, if necessary, 
hands-on facilitation of movements and inhibition
of inappropriate muscle contraction; attention paid
to avoidance of associated proximal movements 
and to relaxation by verbal guidance
Wittenberg 2 weeks Inpatient CIMT: 6 hours/day CIMT: Therapy involved progressively improving Nil reported
2003 on weekdays, 4 motor task performance by a successive 
hours/day on approximation procedure during combined physical,
the weekend occupational and recreational therapy
Alternative: 3 hrs/day, every weekday
Alternative: Therapy aimed to improve task 
performance with the unaffected UL; passive 
stretching to the affected UL for 1 hour during 
the sessions
ADL, activity of daily living; NDT, Neuro-Developmental Therapy (Davies 1985); OT, occupational therapy; PT, physical therapy; ROM,
range of movement; ‘shaping’ is training to achieve a specific motor objective through a series of small steps of progressively increasing
difficulty so that successful performance at each step is likely to occur (Taub and Wolf 1997); UL, upper limb; WMFT, Wolf Motor
Function Test
Study Duration Setting Intensity of Type of therapy Additional
(first author) of trial therapy therapy
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Insufficient data were provided to calculate the effect size
using intention-to-treat data. As almost one-third of
participants did not remain in the group to which they were
allocated, the results of the intention-to-treat analysis
command consideration.
Neither Wittenberg et al (2003) nor Taub et al (1993) matched
the intensity of the therapy provided to the comparison
groups. It is therefore unclear if the observed effects are
attributable to therapy intensity or type. Wittenberg et al
(2003) (PEDro score 6) reported large effect sizes for two of
the three measures of upper limb function at the end of the
intervention period, one of which achieved statistical
significance (Table 6).
Taub et al (1993) (PEDro score 5), in the first randomised
controlled trial investigating the effect of traditional CIMT on
stroke patients, reported significant between-group
differences in three measures of upper limb function.
Observed differences were maintained over the two year
follow-up assessment. More recently, Suputtitada et al (2004)
reported significant between-group differences for two of
three measures of upper limb function. Effect sizes could not
be calculated from published data for either of these trials.
Alberts et al (2004) (PEDro score 6) used measures of
precision grip in addition to global measures of upper limb
function. They reported improvement in the treatment group
for one of two measures of upper limb function but this did
not attain statistical significance (Table 6). There were no
significant between-group differences reported for the
measures of precision grip.
Modified CIMT versus alternative therapy or control Eight
trials (Atteya 2004, Dromerick et al 2000, Page et al 2005,
Page et al 2002, Page et al 2004, Page et al 2001, Ploughman
and Corbett 2004, Ro et al in press) compared mCIMT to
some form of alternative therapy. Time since onset of stroke
for these trials ranged from less than 14 days (Dromerick et al
2000, Page et al 2005, Ro et al in press) to greater than 12
months (Page et al 2004).
The three trials (Dromerick et al 2000, Page et al 2005, Ro et
al in press) that included patients less than 14 days post stroke
were all of relatively high method quality (range 6 to 7) and
all reported a large effect size in favour of the mCIMT group
on their primary measure of upper limb function (Table 6).
However, in the trial by Dromerick et al (2000) the constraint
group was, on average, 10 years younger than the alternative
treatment group, inviting the possibility that age-related
condition changes may explain observed differences between
groups. The duration of these trials differed between two
(Dromerick et al 2000, Ro et al in press) and ten (Page et al
2005) weeks. Participants in the ten week trial received less
intensive therapy over the longer duration when compared
with those in the two week trial. None of these trials followed
patients beyond the intervention period.
The pilot trial by Page et al (2001) (PEDro score 3) compared
two subacute patients in each of three groups. The mCIMT
group appeared to show improvements in upper limb function
with minimal to no change in the alternative and control
groups. These findings were further tested in a subsequent
investigation conducted by Page et al (2002) (PEDro score 4).
They reported non-significant differences between the three
groups for two of three measures of upper limb function. We
were unable to determine effect sizes from the published data.
Atteya et al (2004) (PEDro score 3) used an identical protocol
in patients one to six months post stroke. The small sample
size precluded statistical analysis, however their results
concurred with the earlier trial (Page et al 2001) with the
mCIMT group appearing to result in improvements in upper
limb function with minimal to no change in the alternative
and control groups.
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Table 5. Method quality of included trials.
Study (first Random Concealed Baseline Blind Blind Blind Adequate Intention Between- Point PEDro
author) allocation allocation comparability subjects therapists assessors follow-up to treat group estimates score
analysis compari- and (/10)
sons variability
Alberts 2004 Y N Y N N N Y Y Y Y 6
Atteya 2004 Y N Y N N N Y N N N 3
Dromerick 2000 Y N Y N N Y Y N Y Y 6
Page 2001 Y N N N N Y Y N N N 3
Page 2002 Y N N N N Y Y N Y N 4
Page 2004 Y Y Y N N Y Y N Y Y 7
Page 2005 Y N Y N N Y Y Y Y Y 7
Ploughman 2004 Y N Y N N N N N Y Y* 4
Ro in press Y N Y N N Y Y Y Y Y 7
Sterr 2002 Y N N N N N N N Y Y 3
Suputtitada 2004 Y N Y N N Y Y N Y N 5
Taub 1993 Y N Y N N Y Y N Y N 5
van der Lee 1999 N Y N N N Y Y Y Y Y 6
Wittenberg 2003 Y N Y N N Y Y N Y N 5
*additional data available from author on request
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Table 6. Calculated (standardised) effect sizes and results of meta-analysis.
Study (n) ARA FIM Fugl MAL MAL AOU MAL QOM WMFT
Effect size Effect size Effect size Effect size Effect size Effect size Effect size
(95% CI)* (95% CI)* (95% CI)* (95% CI)* (95% CI)* (95% CI)* (95% CI)*
CIMT vs Alternative Treatment
Suputtitada 2004 (69) ID – – – – –
Taub 1993 (9) – – ID –
van der Lee 1999 # (66) 0.67 0.70 0.63 0.48  –
(0.16 to (0.18 to (0.11 to (–0.04 to
1.19) 1.21) 1.14) 0.98)
Wittenberg 2003 ## (16) – – 1.17 0.75 
(0.10 to (–0.31 to
2.24) 1.73)
CIMT vs Control
Alberts 2004 (10) –0.82 – – – 0.16
(–2.11 to (–1.08 to 
0.47) 1.40)
mCIMT vs Alternative Treatment
Atteya 2004 (6) UD – UD UD UD UD
Dromerick 2000 (20) 0.95 0.02   




Page 2001 (6) UD – UD UD UD UD
Page 2002 (14) ID – ID ID ID –
Page 2004 (17) 0.92 – 1.42 (0.06 ID ID –
(–0.37 to to 2.78)
2.21)
Page 2005 (10) 3.70 – 2.21 6.78 4.25 –
(1.66 to (0.64 to (3.56 to (2.01 to 
5.74) 3.78) 10.00) 6.49)
Ploughman 2004 (23) 0.69 0.57 
(–0.18 to (–0.27 to 
1.51) 1.41)
Ro in press (8) – – 1.90 0.36 0.32 to –
(0.23 to (–1.04 to (–1.08 
3.57) 1.76) 1.71)
mCIMT vs Control
Atteya 2004 (6) UD – UD UD UD UD
Page 2001 (6) UD – UD UD UD UD
Page 2002 (14) ID – ID ID ID –
Page 2004 (17) 2.72 – 2.49 ID ID –
(1.21 to (1.04 to 
4.24) 3.95)
CIMT vs mCIMT
Sterr 2002 (15) – – – 0.57 0.24 ID
(–0.47 (–0.78 to
to1.60) 1.25)
Pooled effect size 0.50
(Fixed Effects Model) (–0.28 to 
1.27)
Pooled effect size 
(Random Effects Model) 1.51 1.16 3.57 2.28
(0.27 to (–0.18 to (–2.63 (–1.56 to 
2.74) 2.52) to 9.77) 6.12)
Bold text indicates data used for and results of meta-analysis; – Not Assessed; ID, insufficient data; UD, unable to determine due
to small sample size; *Based on first measurement post intervention; **Represents the range of FIM scores for the 5 ADL items
reported; #Based on data from final group allocation not group randomised to; ##Based on the pre-intervention standard
deviation
ARA, Action Research Arm Test; FIM, Functional Independence Measure; Fugl, Fugl-Meyer Assessment; MAL, Motor Activity
Log; AOU, amount of use; QOM, quality of movement; WMFT, Wolf Motor Function Test
An identical protocol of restraint, intensity of therapy, and
duration of trial was used in another trial of patients greater
than 12 months post stroke (Page et al 2004). For the two
outcome measures for which sufficient data were available,
calculated effect sizes were large and in favour of mCIMT.
The effect sizes appeared larger when mCIMT was compared
to a no treatment control than when compared with the
alternative therapy (Table 6).
One trial (Ploughman and Corbett 2004) (PEDro score 4)
found non-significant small to moderate effect sizes in favour
of the constraint group on all measures of upper limb function
(Table 6). In this trial, the amount and time of therapy was not
standardised within or between the groups as it was
administered on the basis of patient need.
Traditional CIMT versus modified CIMT Due to differences
in trial populations it was not possible to directly compare the
results of trials using a traditional CIMT protocol with those
using a mCIMT protocol.
Sterr et al (2002) assessed the effects of two different CIMT
protocols (PEDro score 3). Patients in this trial were more
than one year post stroke; both groups received the same
restraint protocol with one group receiving three and the other
six hours of therapy per day. Effect sizes could be calculated
for two sub-scales of the Motor Activity Log. Effects were
small and moderate in favour of the six hour per day group,
with neither of the between group differences achieving
statistical significance (Table 5). Observed differences
remained at the end of the four week follow-up period for
both subscales (Amount of Use effect size 0.90; 95% CI
–0.16 to 1.97 and Quality of Movement effect size 0.56; 95%
CI –0.47 to 1.60).
Activities of daily living, patient satisfaction and quality of
life Three trials (Dromerick et al 2000, Ploughman and
Corbett 2004, van der Lee et al 1999) assessed activities of
daily living. Two trials used the Functional Independence
Measure (Dromerick et al 2000, van der Lee et al 1999), one
trial used the Barthel Index (Dromerick et al 2000), and one
used the Rehabilitation Activities Profile (van der Lee et al
1999). Small to large effects were found in favour of modified
CIMT for five of the six measures on the Functional
Independence Measure (Table 6). Only one, the upper
extremity dressing item (Dromerick et al 2000), attained
statistical significance. No significant differences were
reported for the Barthel Index (effect size 0.57; 95% CI –0.35
to 1.44) or for the Rehabilitation Activities Profile, Personal
Care (effect size –0.16; 95% CI –0.66 to 0.35) and
Occupation (effect size –0.30; 95% CI –0.80 to 0.21) sub-
scales.
Six trials (Atteya 2004, Page et al 2005, Page et al 2002, Page
et al 2001, Taub et al 1993, van der Lee et al 1999) informally
measured compliance and satisfaction with the constraint
protocol through the use of interviews and/or a log book. All
of these trials reported a high level of participant satisfaction
and compliance. One trial (Ploughman and Corbett 2004)
formally assessed compliance with the restraint. They
reported poor compliance with restraint wearing, with no
subjects achieving the target of six hours. The average time
was 2.7 hours per day with one patient unable to wear the
constraint at all.
No trials assessed quality of life.
Harms  Two trials directly reported the harms associated with
the intervention and control treatment (Taub et al 1993, van
der Lee et al 1999). The reported harms were burns (in both
the reference and constraint groups), minor skin lesions (in
the reference group), and muscle soreness resulting in
stiffness and discomfort in the affected upper extremity (in
the constraint group). In the three trials of acute patients
(Dromerick et al 2000, Page et al 2005, Ro et al in press) there
were no adverse events. Ploughman and Corbett (2004)
reported no falls or medical complications requiring re-
admission to acute care. Their measure of shoulder pain
showed a non-significant increase in pain for four of the five
patients in the constraint group.
Costs  Given the intensity of therapy that is required in the
CIMT protocol (up to six hours per day) the potential costs
associated with CIMT could be quite high. No trials assessed
the cost of implementing a CIMT protocol or compared costs
to those incurred using alternative therapy.
Discussion
A considerable research effort has assessed the effects of
CIMT for upper limb hemiparesis following stroke. This
review identified 14 relevant randomised controlled trials.
Only one of the five outcome measures combined in meta-
analysis achieved statistical significance. These results should
be interpreted with some caution, given the small number of
trials, the small sample sizes within the trials and the large
between-trial variation in time since stroke, study quality, and
the CIMT protocol. The effect sizes across the meta-analysis
calculations were all moderate to large and in favour of the
CIMT group. Comparable larger samples, or more trials with
similar outcomes, would have indicated a statistically
significant effect.
To facilitate meta-analysis, standardised measures of activity
and impairment, with acceptable clinimetric properties, are
desirable (Duncan et al 2000). The most common measures of
upper limb function used in included trials were the Action
Research Arm Test, the Wolf Motor Function Test and the
Fugl-Meyer Assessment. All of these outcome measures
involve the assessor scoring the participant’s ability
performing various tasks in a laboratory setting. They have all
been shown to have a high level of reliability and validity (de
Weerdt and Harrison 1986, Duncan et al 1983, Fugl-Meyer et
al 1975, Lyle 1981, van der Lee et al 2001, Wolf et al 2001).
All trials except one used at least one of these measures to
assess outcome but there was no consistency across trials in
the primary outcome measure. The Motor Activity 
Log was developed for assessing the effectiveness of 
CIMT and was used in 11 of the trials included in this 
review. It attempts to address the problems associated 
with assessing upper limb function in the laboratory 
setting through the use of a semi-structured interview of
patients and their care givers to assess the amount and 
quality of use of the affected upper limb in activities of 
daily living. This scale has been found to have good 
internal consistency and reliability, although its 
longitudinal construct validity has been questioned 
(van der Lee et al 2004). The implementation and scoring of
the Motor Activity Log varied across trials. Lack of
standardisation may account for some of the variability 
in effects observed using this outcome measure. It is 
likely that many future trials of CIMT will be conducted 
on small samples. To strengthen potential for meta-analysis, a
standardised set of core outcome measures might be
considered.
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Based on the inclusion criteria for participation in included
trials, only a small proportion of stroke patients may eligible
for CIMT. Two of the included trials reported information
relating to patient eligibility. Of those screened, only 4% (Ro
et al in press) and 18% (Taub et al 1993) were eligible for
inclusion. Researchers conducting a trial currently in progress
had to broaden their inclusion criteria from 3–6 months to
3–9 months post stroke due to problems with recruitment
(Winstein et al 2003). Further studies aiming to determine the
optimal time post stroke to implement CIMT should also
consider the required inclusion criteria to maximise results
and participant eligibility.
CIMT is underpinned by the theory that the duration, amount,
and type of therapy combined with constraint are critical
factors (Taub 1980). Page and colleagues (Page et al 2002)
investigated stroke patients’ and therapists’ opinions of
CIMT. They found that 63% of the 208 patients who returned
the survey reported that they would not participate in CIMT.
The main reasons provided for not wanting to participate
were concerns over the length of time wearing the restrictive
device and the number of days and hours in therapy. Of the 26
occupational therapists and 59 physical therapists who
responded to the questionnaire, 68% thought that CIMT,
when compared to other therapies, would be difficult or very
difficult to administer. The primary concern of these
therapists was the length of time the patients were required to
spend in therapy. Therefore there is a concern that, although
potentially effective, CIMT might not always be feasible. Of
the eight trials that compared a modified form of CIMT with
an alternative treatment, the duration of the trial was
generally extended to ten weeks with participants receiving
half to one hour of therapy three times per week. One trial
reduced the amount of therapy from the traditional six to three
hours and another trial compared six with three hours of
therapy. The results for these trials indicated that a modified
form of CIMT appears to be effective in improving upper
limb function following stroke. The small number of trials
and the limited data do not allow for conclusions regarding
the optimal training frequency and duration.
With regard to the constraint, there is also cause to question
patients’ abilities to comply with the requirements of the
protocol. In all of the trials the participants were required to
wear the constraint at least five hours each day. When the
constraint is worn during therapy time, ensuring adherence is
possible. In the mCIMT protocols, where the majority of
constraint is not under therapist supervision, compliance is
more difficult to ascertain with confidence. Ploughman et al
(2004) identified poor compliance with unsupervised
constraint. Future studies might refine attention to
compliance.
Conclusion
This systematic review identified 14 randomised controlled
trials of CIMT in stroke patients. Evidence that supports the
use of CIMT is growing. CIMT may improve upper limb
function following stroke compared to alternative and/or no
treatment. Little can be concluded about the effects of CIMT
on quality of life, independence with activities of daily living,
and costs associated with the intervention. It is unclear if
there is an optimal CIMT protocol. The findings of this
review can be generalised to people with preserved cognitive
function, 10 degrees of active finger, and 20 degrees of active
wrist extension. Despite the popularity that CIMT currently
enjoys amongst treatment providers, high quality trials
involving larger sample sizes are required before definitive
conclusions can be drawn about the benefit of CIMT over
alternative therapy or no treatment.
Correspondence Sharon Hakkennes, School of
Physiotherapy, La Trobe University, Victoria 3086. Email:
sharonh@barwonhealth.org.au.
References
Alberts JL, Butler AJ and Wolf SL (2004): The effects of
constraint-induced therapy on precision grip: A preliminary
study. Neurorehabilitation and Neural Repair 18: 250–258.
Atteya AA (2004): Effects of modified constraint induced therapy
on upper limb function in subacute stroke patients.
Neurosciences 9: 24–29.
Barreca S, Wolf SL, Fasoli S and Bohannon R (2003): Treatment
interventions for the paretic upper limb of stroke survivors: A
critical review. Neurorehabilitation and Neural Repair
17: 220–226.
Cohen J (1988): Statistical Power Analysis for the Behavioural
Sciences (2nd ed.). New York: Academic Press.
Davies PM (1985): Steps to Follow: A Guide to the Treatment of
Adult Hemiplegia. Berlin: Springer Verlag.
de Weerdt CJ and Harrison MA (1986): Measuring recovery of
arm-hand function in stroke patients: A comparison of the
Brunnstrom-Fugl-Meyer Test and the Action Research Arm
Test. Physiotherapy Canada 37: 65–70.
Dromerick AW, Edwards DF and Hahn M (2000): Does the
application of constraint-induced movement therapy during
acute rehabilitation reduce arm impairment after ischemic
stroke? Stroke 31: 2984–2988.
Duncan PW, Jorgensen HS and Wade DT (2000): Outcome
measures in acute stroke trials: A systematic review and some
recommendations to improve practice. Stroke 31: 1429–1438.
Duncan PW, Propst M and Nelson SG (1983): Reliability of the
Fugl-Meyer Assessment of sensorimotor recovery following
cerebrovascular accident. Physical Therapy 63: 1606–1610.
Fleiss JL (1993): The statistical basis of meta-analysis. Statistical
Methods in Medical Research 2: 121–145.
Fugl-Meyer A, Jaasko L, Leyman I, Olsson S and Steglind S
(1975): The post-stroke hemiplegic patient: A method for
evaluation of physical performance. Scandinavian Journal of
Rehabilitative Medicine 7: 13–31.
Grotta JC, Noser EA, Ro T, Boake C, Levin H, Aronowski J and
Schallert T (2004): Constraint-induced movement therapy.
Stroke 35: 2699–2701.
Knapp H, Taub E and Berman A (1958): Effect of deafferentation
on a conditioned avoidance response. Science 128: 842–843.
Knapp H, Taub E and Berman A (1963): Movements in monkeys
with deafferented forelimbs. Experimental Neurology
7: 305–315.
Lyle R (1981): A performance test for assessment of upper limb
function in physical rehabilitation treatment and research.
International Journal of Rehabilitation Research 4: 483–492.
Maher CG, Sherrington C, Herbert RD, Moseley AM and Elkins M
(2003): Reliability of the PEDro Scale for rating quality of
randomized controlled trials. Physical Therapy 83: 713–721.
Moseley AM, Herbert RD, Sherrington C and Maher CG (2002):
Evidence for physiotherapy practice: A survey of the
Physiotherapy Evidence Database (PEDro). Australian Journal
of Physiotherapy 48: 43–49.
Noser EA, Ro T, Wallace R, Tran T, Salmeron E, Lai J, Gaber M,
Speroni A, Boake C, Zhang L, Levin HS and Grotta JC (2003):
Constraint induced therapy after subacute stroke. Stroke 34: 313.
Page SJ, Levine P and Leonard AC (2005): Modified constraint-
induced therapy in acute stroke: A randomized controlled pilot
study. Neurorehabilitation and Neural Repair 19: 27–32.
Australian Journal of Physiotherapy 2005  Vol. 51230
Hakkennes and Keating: Constraint-induced movement therapy following stroke: A systematic review 
Australian Journal of Physiotherapy 2005  Vol. 51 231
Page SJ, Levine P, Sisto S, Bond Q and Johnston MV (2002):
Stroke patients’ and therapists’ opinions of constraint-induced
movement therapy. Clinical Rehabilitation 16: 55–60.
Page SJ, Sisto S, Johnston MV and Levine P (2002): Modified
constraint-induced therapy after subacute stroke: A preliminary
study. Neurorehabilitation and Neural Repair 16: 290–295.
Page SJ, Sisto S, Levine P, Johnston MV and Hughes M (2001):
Modified constraint induced therapy: A randomized feasibility
and efficacy study. Journal of Rehabilitation Research and
Development 38: 583–590.
Page SJ, Sisto S, Levine P and McGrath RE (2004): Efficacy of
modified constraint-induced movement therapy in chronic
stroke: A single-blinded randomized controlled trial. Archives of
Physical Medicine and Rehabilitation 85: 14–18.
Ploughman M and Corbett D (2004): Can forced-use therapy be
clinically applied after stroke? An exploratory randomized
controlled trial. Archives of Physical Medicine and
Rehabilitation 85: 1417–1423.
Risedal A, Zeng J and Johansson BB (1999): Early training may
exacerbate brain damage after focal brain ischemia in the rat.
Journal of Cerebral Blood Flow and Metabolism 19: 997–1003.
Ro T, Noser EA, Boake C, Wallace R, Gaber M, Speroni A,
Bernstien M, De Joya A, Burgin WS, Zhang L, Taub E, Grotta
JC and Levin HS (in press): Functional reorganisation and
recovery after constraint induced movement therapy in
subacute stroke: Case reports. Neurocase.
Sandercock P, Algra A, Anderson C, Bath P, Bereczki D, Berge E,
Bowen A, Candelise L, Forster A, Fraser H, Hankey G,
Langhorne P, Lewis S, McInnes A, Prasad K and Thomas B
(2003): Collaborative review groups: Stroke group. Cochrane
Database of Systematic Reviews.
Sitori V, Gratti R and Davide C (2003): Constraint induced
movement therapy for upper extremities in stroke patients
(Protocol). Cochrane Database of Systematic Reviews.
Sterr A, Elbert T, Berthold I, Kolbel S, Rockstroh B and Taub E
(2002): Longer versus shorter daily constraint-induced
movement therapy of chronic hemiparesis: An exploratory
study. Archives of Physical Medicine and Rehabilitation
83: 1374–1377.
Suputtitada A, Suwanwela NC and Tumvitee S (2004):
Effectiveness of constraint-induced movement therapy in
chronic stroke patients. Journal of the Medical Association of
Thailand 87: 1482–1490.
Taub E (1977): Movement in nonhuman primates deprived of
somatosensory feedback. Exercise and Sports Sciences
Reviews 4: 335–374.
Taub E (1980): Somatosensory deafferentation research with
monkeys: implications for rehabilitation medicine. In Ince L
(ed.): Behavioural Psychology in Rehabilitation Medicine:
Clinical Applications. New York: Williams & Wilkins, pp.
371–401.
Taub E, Miller N, Novack T, Cook E, Flemming W, Nepomuceno
C, Connel J and Crago JE (1993): Technique to improve
chronic motor deficit after stroke. Archives of Physical Medicine
and Rehabilitation 74: 347–354.
Taub E, Uswatte G and Pidikiti R (1999): Constraint-induced
movement therapy: A new family of techniques with broad
application to physical rehabilitation––a clinical review. Journal
of Rehabilitation Research and Development 36: 237–251.
Taub E and Wolf SL (1997): Constraint induced movement
techniques to facilitate upper extremity use in stroke patients.
Topics in Stroke Rehabilitation 3: 38–61.
van der Lee J, Beckerman H, Lankhorst GJ and Bouter LM
(2001): The responsiveness of the Action Research Arm test
and the Fugl-Meyer Assessment scale in chronic stroke
patients. Journal of Rehabilitation Medicine 33: 110–113.
van der Lee JH (2001): Constraint-induced therapy for stroke:
More of the same or something completely different? Current
Opinion in Neurology 14: 741–744.
van der Lee JH (2003): Constraint-induced movement therapy:
Some thoughts about theories and evidence. Journal of
Rehabilitation Medicine Suppl 41: 41–45.
van der Lee JH, Beckerman H, Knol DL, de Vet HCW and Bouter
LM (2004): Clinimetric properties of the Motor Activity Log for
the assessment of arm use in hemiparetic patients. Stroke
35: 1410–1414.
van der Lee J, Snels I, Beckerman H and Lankhorst GJ (2001):
Exercise therapy for arm function in stroke patients: A
systematic review of randomized controlled trials. Clinical
Rehabilitation 15: 20–31.
van der Lee JH, Wagenaar RC, Lankhorst GJ, Vogelaar TW,
Deville WL and Bouter LM (1999): Forced use of the upper
extremity in chronic stroke patients: Results from a single-blind
randomized clinical trial. Stroke 30: 2369–2375.
Van Peppen RPS, Kwakkel G, Wood–Dauphinee S, Hendriks
HJM, Van der Wees PJ and Dekker J (2004): The impact of
physical therapy on functional outcomes after stroke: What’s
the evidence? Clinical Rehabilitation 18: 833–862.
Winstein CJ, Miller JP, Blanton S, Taub E, Uswatte G, Morris D,
Nichols D and Wolf S (2003): Methods for a multisite
randomized trial to investigate the effect of constraint-induced
movement therapy in improving upper extremity function
among adults recovering from a cerebrovascular stroke.
Neurorehabilitation and Neural Repair 17: 137–152.
Wittenberg GF, Chen R, Ishii K, Bushara KO, Taub E, Gerber LH,
Hallett M and Cohen LG (2003): Constraint-induced therapy in
stroke: Magnetic-stimulation motor maps and cerebral
activation. Neurorehabilitation and Neural Repair 17: 48–57.
Wolf SL, Catlin PA, Ellie M, Archer AL, Morgan B and Piacentino
A (2001): Assessing Wolf Motor Function Test as outcome
measure for research in patients after stroke. Stroke 
32: 1635–1639. 
Hakkennes and Keating: Constraint-induced movement therapy following stroke: A systematic review 
